Viralgen Commercial
Entry
2019
Hold
2yr
Exit
2021
Who owns Viralgen Commercial?
Viralgen Commercial was owned by Columbus Venture Partners through Columbus Life Science Fund II (2019 vintage) from 2019 to 2021, exited via Trade Sale.
Buyer identity available on Pro.
Hand-verified · updated 2026-08-09
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2021
More from Columbus Life Science Fund II
Other portfolio companies in the same fund.
Minoryx Therapeutics
Active
Biotech
Spain· 2022
Spain· 2022NeRRe Therapeutics
Active
Biotech
United Kingdom· 2021
United Kingdom· 2021Highlight Therapeutics
Active
BiotechSpain· 2020
Spain· 2020RECOVID Solutions
Exited 2022
HealthTechSpain· 2020
Spain· 2020to
Sanifit Therapeutics
Exited 2021
BiotechSpain· 2019
Spain· 2019to
Radioterapia de Protones
Exited 2024
HealthcareSpain· 2017
Spain· 2017to
More PE-backed in Biotech
Comparable biotech deals from other GPs.
FranceTrack Viralgen Commercial
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Viralgen Commercial.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue